About

Using generative biology and chemistry, we are revolutionizing the speed and accuracy of how medicine is created.

Our HyperloopTM Platform combines deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure to create candidate-ready compounds with unprecedented speed.

Our Core Values:

  • Urgency: We move swiftly and purposefully to address critical unmet patient needs.
  • Resilience: We persist in the face of challenges, turning setbacks into opportunities.
  • Collaboration: We build strong partnerships and value diverse perspectives.
  • Transparency: We build trust through openness, directness, and accountability.
  • Compassion: We lead with empathy, always keeping patients at the heart of our mission.

Investors

Our Team

Staff

Aaron Plys

Connect with Aaron Plys on LinkedIn
Principal Scientist, Biology

Ajay Yekkirala

Connect with Ajay Yekkirala on LinkedIn
Chief Scientific Officer

Alix Rouault

Connect with Alix Rouault on LinkedIn
Sr. Scientist, Biology

Cameron Russell

Connect with Cameron Russell on LinkedIn
Senior Research Associate, Biology

Charles Norsigian

Connect with Charles Norsigian on LinkedIn
Staff Software Engineer, Digital Technologies

Cheri Ross

Connect with Cheri Ross on LinkedIn
Sr. Scientist, Lead Generation

Chi-Li Chen

Connect with Chi-Li Chen on LinkedIn
Executive Director, CMC

Chris Oalmann

Connect with Chris Oalmann on LinkedIn
VP, Head of LEADs

Colin Gauvin

Connect with Colin Gauvin on LinkedIn
Sr. Scientist, Protein Design & Structure

Cony D’Cruz

CEO

Daniel Li

Connect with Daniel Li on LinkedIn
Staff Accountant

Dilinie Fernando

Connect with Dilinie Fernando on LinkedIn
Principal Scientist, Medicinal Chemistry

Elaine Krueger

Connect with Elaine Krueger on LinkedIn
VP, Head of IDEAs

Elena Longhi

Connect with Elena Longhi on LinkedIn
Sr. Scientist, Lead Generation

Eric Sanford

Connect with Eric Sanford on LinkedIn
Research Scientist, Biology

Erin Burry

Connect with Erin Burry on LinkedIn
Accounting Manager

Florentina Tofoleanu

Connect with Florentina Tofoleanu on LinkedIn
Associate Director, Computational Chemistry

Galip Yiyen

Connect with Galip Yiyen on LinkedIn
Lab Technician, Protein Design & Structure

Haoxuan Wang

Connect with Haoxuan Wang on LinkedIn
Sr. Scientist, Lead Generation

Heike Schoenherr

Connect with Heike Schoenherr on LinkedIn
Sr. Director, Head of Lead Generation

Hongtao Zeng

Connect with Hongtao Zeng on LinkedIn
Sr. Lab Scientist, Exploratory Biology

Jasmine Nguyen

Connect with Jasmine Nguyen on LinkedIn
Lab Operations Manager

Jenny Herman

Connect with Jenny Herman on LinkedIn
SVP, Finance

Jill Sutt

Connect with Jill Sutt on LinkedIn
Executive Director, Clinical Development & Operations

Katelyn Billings

Connect with Katelyn Billings on LinkedIn
Chief of Staff, Head of Program and Alliance Management

Kayla Tift

Connect with Kayla Tift on LinkedIn
Associate Director, Operations & HR

Kelley Shortsleeves

Connect with Kelley Shortsleeves on LinkedIn
Principal Scientist, Lead Generation

Ken Borrelli

Connect with Ken Borrelli on LinkedIn
Sr. Director, Head of Computation

Mark Fitzgerald

Connect with Mark Fitzgerald on LinkedIn
Director, Medicinal Chemistry

Melanie Chien

Connect with Melanie Chien on LinkedIn
Senior Research Associate, Biology

Michael Robertson

Connect with Michael Robertson on LinkedIn
Associate Director, Protein Design & Structure

Min-Sun Park

Connect with Min-Sun Park on LinkedIn
Associate Director, Computational Chemistry

Mira Khazanchi

Connect with Mira Khazanchi on LinkedIn
Research Associate, Biology

Molly Premtoon

Connect with Molly Premtoon on LinkedIn
Sr. Scientist, Computational Chemistry

Murco Ringnalda

Connect with Murco Ringnalda on LinkedIn
Chief Financial Officer

Neil Lajkiewicz

Connect with Neil Lajkiewicz on LinkedIn
Associate Director, Medicinal Chemistry

Olivia Pierce

Connect with Olivia Pierce on LinkedIn
Director, Computational Chemistry

Rulin Ma

Connect with Rulin Ma on LinkedIn
Principal Scientist, Medicinal Chemistry

Ryan Bloom

Connect with Ryan Bloom on LinkedIn
SVP, Business Development and Operations

Sam Malekiani

Connect with Sam Malekiani on LinkedIn
Associate Vice President, Toxicology

Samantha Figueroa

Connect with Samantha Figueroa on LinkedIn
Business Operations Specialist

Shivani Sharma

Connect with Shivani Sharma on LinkedIn
Scientist, Protein Design & Structure

Sujatha Kumar

Connect with Sujatha Kumar on LinkedIn
VP, Head of BRIDGE

Theresa Baker Tran

Connect with Theresa Baker Tran on LinkedIn
Sr. Lab Scientist, Biology

Unnati Pandya

Connect with Unnati Pandya on LinkedIn
Principal Scientist, Biology

Xin Sun

Connect with Xin Sun on LinkedIn
Director, Head of Biology

Yung-Chi Huang

Sr. Scientist, Biology

Zhonghui Xu

Connect with Zhonghui Xu on LinkedIn
Senior Engineer, Machine Learning

Join Our Team

Join us to accelerate new possibilities in drug discovery.

Careers

Scientific Advisory Board

Carrie Haskell-Luevano, PhD

Philip S. Portoghese Endowed Chair in Chemical Neuroscience
Institute for Translational Neuroscience Scholar
Department of Medicinal Chemistry, University Of Minnesota

Georgia McGaughey, PhD

Connect with Georgia McGaughey, PhD on LinkedIn
Trilligant LLC, Founder

John Griffin, PhD

Connect with John Griffin, PhD on LinkedIn

Morris J. Birnbaum, MD PhD (Chair)

Connect with Morris J. Birnbaum, MD PhD (Chair) on LinkedIn
Professor Emeritus, University of Pennsylvania

Sandeep Menon, MD, PhD

Connect with Sandeep Menon, MD, PhD on LinkedIn
Chief Research & Development Officer, BioCryst Pharmaceuticals

Terry Kenakin

Connect with Terry Kenakin on LinkedIn
Professor, Department of Pharmacology
University of North Carolina- School of Medicine

Board of Directors

Nandita Shangari

Managing Director- RA Capital Management

Cony D’Cruz

CEO - Superluminal Medicines

Diamantis Xylas, MD

Partner & Head of Research - Catalio Capital Management, LP

Dylan Morris

Managing Director, Biotechnology - Insight Partners

News & Insights

View All Posts

Published August 2025

“Biopharma returns to MC4R for drugs targeting genetic obesity as well as appetite loss.” Featured Story on Endpoints News by Kyle LaHucik

Read more
Published August 2025

Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity

Read more
Published August 2025

Superluminal Medicines Announces a Selective, Biased, MC4R Agonist is Advancing to IND-enabling Studies for the Treatment of Obesity

Read more

Explore More

Science

Our HyperloopTM Platform unites novel structure-based drug discovery with AI-driven computational approaches and experimental readouts to discover and validate small molecule therapeutics.

Our Platform

Pipeline

With an initial focus on GPCRs, our pipeline combines scientific ingenuity with patient-focused precision, developing next-generation treatments for cardiometabolic diseases.

Our Pipeline